Clinical Trial Update: Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a cancer vaccine in combination with the QS-21 adjuvant for small cell lung cancer that has responded to initial therapy has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• QS-21 adjuvant (QS-21 adjuvant)
• cancer vaccine (unspecified)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED